Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.517,20
-0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Artelo Biosciences Inc (ARTL) Artelo Biosciences Inc (ARTL) Notizie

Artelo Biosciences Inc

ARTL
1,25
-0,09 (-6,72%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/4/202414:30GLOBEArtelo Biosciences Announces Publication of Peer-Reviewed..
22/4/202414:30GLOBEArtelo Biosciences CEO to Appear on Benzinga All Access on..
25/3/202413:00GLOBEArtelo Biosciences Reports Fiscal 2023 Year-End Financial..
12/3/202414:15GLOBEArtelo Biosciences Selected as a Finalist in Johnson &..
23/1/202414:30GLOBEArtelo Biosciences Announces Publication of New..
08/1/202414:30GLOBEArtelo Biosciences Announces Selection of Worldwide Clinical..
05/12/202314:30GLOBEArtelo Biosciences Presents New Preclinical Data on ART12.11..
30/11/202315:00GLOBEArtelo Biosciences to Present Important New Preclinical Data..
13/11/202314:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:00GLOBEArtelo Biosciences Reports Third Quarter 2023 Financial..
09/11/202315:00GLOBEArtelo Biosciences Announces Publication of New..
02/11/202313:30GLOBEArtelo Biosciences to Present Preclinical Data Showcasing..
04/10/202314:30GLOBEPrincipal Investigator of Artelo’s CAReS Trial to..
13/9/202314:30GLOBEArtelo Biosciences to Present at the 13th Congress of the..
07/9/202314:00GLOBEArtelo Biosciences Completes Positive Pre-IND Meeting with..
06/9/202315:00GLOBEArtelo Biosciences to Present at the 6th Cannabinoid-Derived..
05/9/202315:00GLOBEArtelo Biosciences to Present at the H.C. Wainwright 25th..
10/8/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:00GLOBEArtelo Biosciences Reports Second Quarter 2023 Financial..
08/8/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:34EDGAR2Form 8-K - Current report
19/7/202315:00GLOBEArtelo Biosciences to Present New Mechanism of Action Data..
17/7/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
10/7/202314:30GLOBEArtelo Biosciences CEO to Participate in the Benzinga All..
07/7/202314:23EDGAR2Form DEL AM - Delaying amendment
06/7/202322:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/7/202320:15EDGAR2Form 8-K - Current report
03/7/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202314:30GLOBEArtelo Biosciences Announces Sponsorship of The William A...
27/6/202314:30GLOBEArtelo Biosciences Announces Important New Data on ART26.12..
26/6/202314:30GLOBEArtelo Biosciences Reports Superior Preclinical..
07/6/202314:30GLOBEArtelo Biosciences Selected for Oral Presentation to Report..
11/5/202314:00GLOBEArtelo Biosciences Reports First Quarter 2023 Financial..
Apertura: 1,36 Min: 1,3109 Max: 1,36
Chiusura: 1,34

La tua Cronologia

NASDAQ
ARTL
Artelo Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network